Lilly To Diversify Pain Pipeline With SiteOne Acquisition

 
• By Joseph Haas
  
Lilly is acquiring SiteOne to add a non-opioid pain candidate to its pipeline (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Neurological